← ANALYST RATINGS · TIPRANKS
Mobia Medical, Inc. (MOBI): analyst forecast and price target
Analyst consensus
Moderate Buy2 Buy0 Hold0 Sell
Ratings of 2 analysts in the last 3 months · top analysts only12-month forecast
Based on 2 price targets given in the last 3 months, the average target is $16.50, the highest $17.00, the lowest $16.00. The average is +104.0% from the last price of $8.09.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $16.00 | Buy | +97.8% | Reiterated | 17.09.26on TipRanks 07:45 | +0.3%next day −3.1% · 5 days −19.7% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $15.00 → $17.00+13.3% | Buy | +110.1% | Reiterated | 12.08.26on TipRanks 07:55 | −8.7%next day +0.7% · 5 days −0.4% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | $31.00 | Buy | +283.2% | Reiterated | 14.07.26on TipRanks Jul 15 08:13 | +1.1%next day +1.8% · 5 days +4.1% | ↗ |
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | $19.00 | Buy | +134.9% | Reiterated | 22.06.26on TipRanks Jun 23 17:35 | −2.4%next day +0.4% · 5 days +4.1% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Mobia Medical, Inc.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $21.33 at a price of $9.45 (+125.7%); now: $16.50 at $8.09 (+104.0%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Best top-analyst consensus in the sector · General
About Mobia Medical, Inc.
- CEO: Richard Foust
- Employees: 167
- 2802 Flintrock Trace, Austin, TX, 78738, US
- www.mobia.com
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
Data from the stock’s TipRanks forecast page, read 244 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗